In this study, we apply novel multiplex immunoassays to interrogate biomarkers of ferroptosis and pyroptosis and provide evidence that a commonly used ferroptosis inducer, the GPx4 inhibitor RSL3, also induces pyroptosis in cancer cells. This evidence concerns the gene GPX4 and cancer.